Search:

< Go Back

Human Longevity, Inc. Hires Industry Experts Barry Merriman, Ph.D., and Paul Mola, M.S. to Lead New Global Solutions Initiative
Everett Laboratories And Quinnova Pharmaceuticals Start To Operate As Exeltis Brand
AtheroNova Announces Closing of Public Offering of Common Stock and Warrants
CPhI Worldwide 2014 Announces Biggest Ever Show and Points to Pharma Growth in Brazil, Russia and Fast Emerging Africa
Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community
The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF
Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma
Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston
Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting
Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized Dosing with Hizentra®
Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures
GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City
Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses
Quinterol Mallette Appointed to GenVec Board Of Directors
Report: Stem Cell Technologies Market Growing
Asterias Biotherapeutics to Report Third Quarter Results on November 10, 2014
Dyadic International Extends All Convertible Debt Maturity Dates
Discovery Labs Announces Organizational Change and Enhanced Expertise in Neonatology
Dyadic International To Announce Third Quarter 2014 Financial Results And Host Conference Call On Thursday, November 13, 2014
WaferGen Bio-systems Announces Third Quarter 2014 Conference Call
Synageva BioPharma Reports Third Quarter 2014 Financial Results
Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call
Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2014
Innovative Educational Program Takes First Place in National Voya Unsung Heroes™ Awards Competition
China Independent Clinical Laboratory Industry Report, 2014-2017
ABIVAX Strengthens Executive Management Team With Senior Appointments
Glenmark's Consolidated Revenue Increases by 14.85% to Rs. 16,807.08 Mn in Q2 FY 14-15
Diffusion Pharmaceuticals to Present at Cavendish Global Health Impact Forum
Thinklabs One Electronic Stethoscope Helps Physicians Overcome Challenges of Treating Ebola Patients while Wearing Personal Protective Equipment
Hundreds Of Children In Afghanistan Receive Free Hearing Aids Portuguese Spanish
Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China
Chugai licenses ISPRI/OptiMatrix platform from EpiVax for de-risking biologics
HEMACORD®, the First FDA-Licensed Stem Cell Product, Wins Prix Galien USA "Best Biotechnology Product" Award
Roka Bioscience to Report Third Quarter 2014 Financial Results On November 6, 2014
Lupus Research Institute Awards $1-Million Grants to Discover What Causes Lupus
AnaMar AB Reports Top-Line Results from Exploratory Phase 2a Study of AMAP102 and Provides Corporate Update
Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014
Immersive Introduces Oculus DDRM™ First-of-its-Kind, Data-Driven Information Risk Management Framework
Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma
China Biologic to Report Third Quarter 2014 Financial Results
Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing
WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
Novocure™ Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer Spanish
Regado Biosciences to Provide Third Quarter 2014 Financial Results
WHEATON® Highlights Unique Products at AAPS 2014 Providing Purpose-Built Solutions for the Pharmaceutical Industry
Can-Fite to Participate in BIO-Europe International Partnering Conference
Omidria™ Granted Pass-Through Reimbursement Status from CMS

< Prev Next >
PR Newswire - United Business Media